Fleck Christian, Sutter Laura, Appenroth Dorothea, Koch Berit, Meinhold Tobias, Pitack Melanie, Gasser Rodolfo
Institute of Pharmacology and Toxicology, Friedrich Schiller University Jena, Germany.
Exp Toxicol Pathol. 2003 Jun;54(5-6):401-10. doi: 10.1078/0940-2993-00289.
Gene expression profiling using microarrays (rat-specific array RG-U34A, Affymetrix, U.S.A.) was employed for the investigation of: (1) hormonal regulation of renal function and (2) nephrotoxicity. For this purpose about 8,800 genes were analysed in kidney and, additionally, in liver tissue. Ad 1.) Kidney functions develop during postnatal life. Thus, in vivo transport and accumulation of p-aminohippurate (PAH) was investigated on renal cortical slices (RCS) from 10- and 55-day-old rats. The animals were treated with dexamethasone (DEXA; 60 microg/100 g b.wt./day) for 3 days, which caused a significant reduction in the accumulation of PAH in 10-day-old rats (42 +/- 5% whereas it was only slightly reduced in 55-day-old rats (70 +/- 8%). To further clarify the regulation of renal function by DEXA, results were compared with those obtained previously after in vitro stimulation with DEXA. RCS were incubated for 24 hours in DEXA-containing medium (10(-9) M). Under these conditions DEXA significantly increased the PAH uptake capacity in RCS obtained from 10- and 55-day-old rats up to 126 and 136%, respectively. Thus a stimulation of tubular transport capacity is possible in vitro. The effect of DEXA treatment on the gene expression of the kidney (in vivo) was moderate. Focussing especially on transporters, ion channels, ATPases, glucuronyltransferases, glutathione-S-transferase and cytochrome P450, the expression of only few genes were significantly changed (3 to 50-fold up- or down-regulation). Moreover, distinct age differences were found after in vivo administration of DEXA. The investigation of in vitro effects of DEXA is currently been performed. Ad 2.) The kidney is threatened by nephrotoxins because of its ability to accumulate them. We used a single administration of uranyl nitrate (UN; 0.5 mg/100 g b.wt.) as a model for chronic renal failure (CRF). Clearance experiments were performed 10 weeks after UN administration (maximal symptoms of CRF) in adult female rats. As expected, UN induced interstitial cicatrices with reduced GFR and diminished PAH transport capacity. Despite the impressive morphological and functional changes in the kidney after exposure to UN, the gene expression profiles in the kidneys were only minimally affected: we found significantly changed expression levels for only 20 genes (5 genes were up-regulated [e.g. transgelin], 15 down-regulated [among these the Na-K-Cl-symporter, insulin-like growth factor, kallikrein, and ornithine decarboxylase). The lack of agreement between gene expression data and the nephrotoxic effects of UN can probably be explained by the long time interval between dosing and the assessment of the effect. The results confirm that primary genomic responses are likely to be strongest transiently after exposure and then decrease in intensity.
使用微阵列(大鼠特异性阵列RG-U34A,美国Affymetrix公司)进行基因表达谱分析,以研究:(1)肾功能的激素调节和(2)肾毒性。为此,对肾脏以及肝脏组织中的约8800个基因进行了分析。1.)肾功能在出生后发育。因此,研究了10日龄和55日龄大鼠肾皮质切片(RCS)中对氨基马尿酸(PAH)的体内转运和蓄积情况。动物用 dexamethasone(DEXA;60μg/100g体重/天)处理3天,这导致10日龄大鼠中PAH的蓄积显著减少(42±5%),而55日龄大鼠中仅略有减少(70±8%)。为了进一步阐明DEXA对肾功能的调节作用,将结果与之前体外DEXA刺激后获得的结果进行了比较。RCS在含DEXA的培养基(10⁻⁹M)中孵育24小时。在这些条件下,DEXA分别使10日龄和55日龄大鼠的RCS中PAH摄取能力显著增加至126%和136%。因此,体外刺激肾小管转运能力是可能的。DEXA处理对肾脏(体内)基因表达的影响是中等的。特别关注转运体、离子通道、ATP酶、葡糖醛酸转移酶、谷胱甘肽-S-转移酶和细胞色素P450,只有少数基因的表达有显著变化(上调或下调3至50倍)。此外,体内给予DEXA后发现了明显的年龄差异。目前正在进行DEXA体外作用的研究。2.)肾脏因其蓄积肾毒素的能力而受到威胁。我们使用单次给予硝酸铀酰(UN;0.5mg/100g体重)作为慢性肾衰竭(CRF)的模型。在成年雌性大鼠中,给予UN 10周后(CRF的最大症状)进行清除实验。如预期的那样,UN诱导了间质瘢痕形成,伴有肾小球滤过率降低和PAH转运能力减弱。尽管暴露于UN后肾脏出现了令人印象深刻的形态和功能变化,但肾脏中的基因表达谱仅受到最小程度的影响:我们仅发现20个基因的表达水平有显著变化(5个基因上调[如转胶蛋白],15个基因下调[其中包括钠-钾-氯同向转运体、胰岛素样生长因子、激肽释放酶和鸟氨酸脱羧酶])。基因表达数据与UN的肾毒性作用之间缺乏一致性可能可以通过给药与效应评估之间的长时间间隔来解释。结果证实,初次基因组反应在暴露后可能在短时间内最强,然后强度降低。